The Essential

Susan Ridlen is ‘Not Leaving the Institutional World’ Despite Leaving Eli Lilly

While finding Lilly’s decision to outsource its $25B portfolio “a bit of a shock,” the Lifetime Achievement Award winner is excited to share her expertise to the industry.

Will Private Equity’s ‘Window of Opportunity’ Last?

PE firms have cleared their books of some long-held assets now that buyers and sellers have both gotten more realistic about prices. 

Sponsored

As U.S. Stocks Hit Records, Do Mexican Equities Offer Diversification Opportunities?

Large Universities Like Michigan Benefited from Early Bets on AI, Crypto

MPI’s Michael Markov says, “it is plausible that AI and digital-asset exposure is now large enough to affect overall results.”

Related Content

In an Industry Plagued by Short-Termism, Susan Ridlen Is Playing the Long Game

Alicia McElhaney

Eli Lilly’s Susan Ridlen to Receive Lifetime Achievement Award

Alicia McElhaney

How Andy Golden Reinvented the Endowment Model for Princeton

Alicia McElhaney

Job Board – For Investors Only

Investment Analyst
​

University of Virginia

​
Learn More

Investment Analyst
​

DUMAC Inc

​
Learn More

Investment Analyst
​

DUMAC Inc

​
Learn More

Investment Analyst
​

BlueCross BlueShield Association

​
Learn More

1270 Avenue of the Americas, Suite 1120

New York, NY 10020

 

© Institutional Investor, LLC. All material subject to strictly enforced copyright laws. Please read our Terms and Conditions and Privacy Policy before using the site. Institutional Investor is part of Delinian.

 

| Unsubscribe

LinkedIn
X
Bluesky
Instagram